Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Viatris Inc., a global healthcare company formed through the merger of Mylan and Upjohn, is headquartered in the United States. Established in 2020, Viatris operates in over 165 countries, focusing on the pharmaceutical industry with a commitment to providing access to high-quality medicines. The company’s core business areas include generic and specialty pharmaceuticals, biosimilars, and over-the-counter products.
Viatris is renowned for its extensive portfolio, which features a diverse range of medications that address various health conditions, including chronic diseases and infectious diseases. Its unique approach combines a broad product offering with a strong emphasis on patient access and affordability. With a significant market presence, Viatris has achieved notable milestones, including the successful integration of its legacy companies and a commitment to sustainable healthcare solutions.
+6 vs industry average
Viatris’s score of 48 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
Viatris, headquartered in the US, has reported its carbon emissions data for several years. In 2024, the company's total greenhouse gas (GHG) emissions, encompassing Scope 1, 2, and 3, were approximately 2.45 billion kg CO2e. This comprised about 95 million kg CO2e from Scope 1, approximately 260 million kg CO2e from Scope 2 (market-based), and roughly 2.15 billion kg CO2e from Scope 3 emissions.
For 2023, Viatris reported a total of approximately 2.50 billion kg CO2e, with Scope 1 emissions at about 96 million kg CO2e, Scope 2 (market-based) at approximately 259 million kg CO2e, and Scope 3 at around 2.15 billion kg CO2e.
Viatris is committed to reducing its environmental impact. The company has set near-term targets to reduce its absolute Scope 1 and 2 GHG emissions by 42% by 2030, using a 2020 baseline. Additionally, Viatris aims to reduce its absolute Scope 3 GHG emissions by 25% within the same timeframe, covering categories such as purchased goods and services, capital goods, fuel and energy-related activities, and upstream transportation and distribution. These targets have been validated by the Science Based Targets initiative (SBTi) as being consistent with a 1.5°C warming scenario.
Historical data shows a varied emissions profile, with total emissions for 2022 estimated at around 2.33 billion kg CO2e, and for 2021 at approximately 2.41 billion kg CO2e. Earlier years, such as 2019, reported Scope 1 and 2 emissions totalling approximately 667 million kg CO2e. The company also has a long-term ambition for its UK location to achieve net zero GHG emissions by 2050.
Access structured emission data, company specific factors and auditable source documents
2030
42% reduction in Scope 1
Viatris Inc. commits to reduce absolute scope 1 GHG emissions 42% by 2030 from a 2020 base year.
2030
42% reduction in Scope 2
Viatris Inc. commits to reduce absolute scope 2 GHG emissions 42% by 2030 from a 2020 base year.
2030
25% reduction in scope 3 total
Viatris Inc. also commits to reduce absolute scope 3 GHG emissions covering purchased goods and services, capital goods, fuel and energy rel…
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


Common questions about Viatris’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more